Who invested in Elysium Health

2 rounds we have observed, with the 2 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$25Mraised across 2 rounds since 2016, from 2 sources

$20MSeries B$5.0MRound

Latest round: Round, $5.0MJun 2017
Biggest round: $20MSeries B · Dec 2016
Investors: 2

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2017

$20MSeries B$5.0MRound

First round: Series B, $20M
Biggest round: $20M
Between rounds: 7 months

The rounds

Jun 2017
Round$5.0M1 new
- SVB Capital
Reported by FinSMEs
Dec 2016
Series B$20M1 new
- General Catalyst
Reported by FinSMEsSEC filing: $20M sold, first sale Oct 2016

Founders and team

From Elysium Health's own website and the SEC filings it signed: 6 on the team.

Eric MarcotulliCEO
Dan AlminanaCOO
Mark MorrisChief Product Officer
Jason AndersonVP, Engineering
Whitney ChristopherVP, Communications & Brand Marketing
Daniel AlminanaExecutive Officer, Director, Promoteri

On the board, as filediDavid P. FialkowJim P. Manzi

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Series B2016Round2017

General Catalyst

SVB Capital

Everyone who backed them

General CatalystVC firm1round

SVB CapitalVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 5 firms list Elysium Health as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.